eli lilly glp-1 pill data Lilly's Obesity Shows Promising Weight Loss in New Results 3 Companies at the Forefront
Description
The real shift isnt just the molecule its usability
In a phase 2 study, amycretin showed a mean weight reduction of up to 24.3%, which is comparable to or even greater than the weight loss seen with tirzepatide and similar to the results for retatrutide
Explore natural alternatives to GLP-1 drugs like Ozempic and Mounjaro
Learn how GLP-1 can help
Side Effects: As a GLP-1 therapy, common side effects are typically gastrointestinal, including nausea, vomiting, and diarrhea.
Methods We conducted a population-based propensity-matched retrospective cohort study using TriNetX
